150 related articles for article (PubMed ID: 36923437)
1. Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: Computational simulation based on circulating blood cells.
Kim N; Shin J; Ahn SH; Pyo H; Noh JM; Yang K; Lee W; Park B
Front Oncol; 2023; 13():1119173. PubMed ID: 36923437
[TBL] [Abstract][Full Text] [Related]
2. Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy.
Kim N; Myoung Noh J; Lee W; Park B; Park H; Young Park J; Pyo H
Radiother Oncol; 2021 Mar; 156():166-173. PubMed ID: 33359267
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis.
Kim N; Noh JM; Lee W; Park B; Pyo H
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298711
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study.
Jing W; Liu Y; Zhu H; Welsh J; Gandhi S; Jeter M; Nguyen Q; Chen AB; O'Reilly M; Liao Z; Chang JY; Lee P; Lin SH
Clin Transl Radiat Oncol; 2021 May; 28():54-61. PubMed ID: 33778173
[TBL] [Abstract][Full Text] [Related]
5. Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated With Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study.
Yang Y; Muller OM; Shiraishi S; Harper M; Amundson AC; Wong WW; McGee LA; Rwigema JM; Schild SE; Bues M; Fatyga M; Anderson JD; Patel SH; Foote RL; Liu W
Front Oncol; 2022; 12():843175. PubMed ID: 35311159
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcome After Pencil Beam Scanning Proton Therapy of Patients With Non-Metastatic Malignant and Benign Peripheral Nerve Sheath Tumors.
Bachmann N; Leiser D; Pica A; Bachtiary B; Weber DC
Front Oncol; 2022; 12():881665. PubMed ID: 35832560
[TBL] [Abstract][Full Text] [Related]
7. Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.
Jing W; Xu T; Wu L; Lopez PB; Grassberger C; Ellsworth SG; Mohan R; Hobbs BP; Blumenschein GR; Tu J; Altan M; Lee P; Liao Z; Lin SH
JTO Clin Res Rep; 2022 Sep; 3(9):100391. PubMed ID: 36089921
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer.
Wu CT; Motegi A; Motegi K; Hotta K; Kohno R; Tachibana H; Kumagai M; Nakamura N; Hojo H; Niho S; Goto K; Akimoto T
Jpn J Clin Oncol; 2016 Nov; 46(11):1008-1014. PubMed ID: 27511988
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
[TBL] [Abstract][Full Text] [Related]
10. Optimal Target Delineation and Treatment Techniques in the Era of Conformal Photon and Proton Breast and Regional Nodal Irradiation.
Kowalski ES; Feigenberg SJ; Cohen J; Fellows Z; Vadnais P; Rice S; Mishra MV; Molitoris JK; Nichols EM; Snider JW
Pract Radiat Oncol; 2020; 10(3):174-182. PubMed ID: 31786234
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric and NTCP advantages of robust proton therapy over robust VMAT for Stage III NSCLC in the immunotherapy era.
Dionisi F; Landoni V; Widesott L; Nardangeli A; Fracchiolla F; Siniscalchi B; Soriani A; Turkaj A; Righetto R; Amelio D; Farace P; Goanta L; Trianni A; Lorentini S; Cianchetti M; Sanguineti G
Phys Med; 2024 Jun; 123():103410. PubMed ID: 38878630
[TBL] [Abstract][Full Text] [Related]
12. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
13. Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
Liao Z; Lee JJ; Komaki R; Gomez DR; O'Reilly MS; Fossella FV; Blumenschein GR; Heymach JV; Vaporciyan AA; Swisher SG; Allen PK; Choi NC; DeLaney TF; Hahn SM; Cox JD; Lu CS; Mohan R
J Clin Oncol; 2018 Jun; 36(18):1813-1822. PubMed ID: 29293386
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
Yu NY; DeWees TA; Voss MM; Breen WG; Chiang JS; Ding JX; Daniels TB; Owen D; Olivier KR; Garces YI; Park SS; Sarkaria JN; Yang P; Savvides PS; Ernani V; Liu W; Schild SE; Merrell KW; Sio TT
Clin Lung Cancer; 2022 Dec; 23(8):e526-e535. PubMed ID: 36104272
[TBL] [Abstract][Full Text] [Related]
15. Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience.
Bhangoo RS; DeWees TA; Yu NY; Ding JX; Liu C; Golafshar MA; Rule WG; Vora SA; Ross HJ; Ahn DH; Beamer SE; Jaroszewski DE; Hallemeier CL; Liu W; Ashman JB; Sio TT
Adv Radiat Oncol; 2020; 5(5):871-879. PubMed ID: 33083649
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Clinical Safety of High-Dose Proton Radiation Therapy Delivered With Pencil Beam Scanning Technique for Extracranial Chordomas and Chondrosarcomas in Adult Patients: Clinical Evidence of Spinal Cord Tolerance.
Stieb S; Snider JW; Placidi L; Kliebsch U; Lomax AJ; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):218-225. PubMed ID: 29029887
[TBL] [Abstract][Full Text] [Related]
17. Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer.
Lin LL; Vennarini S; Dimofte A; Ravanelli D; Shillington K; Batra S; Tochner Z; Both S; Freedman G
Acta Oncol; 2015 Jul; 54(7):1032-9. PubMed ID: 25789715
[TBL] [Abstract][Full Text] [Related]
18. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
19. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
[TBL] [Abstract][Full Text] [Related]
20. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
Lomax AJ; Cella L; Weber D; Kurtz JM; Miralbell R
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):785-92. PubMed ID: 12573766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
